Neither regional nor systemic chemotherapy significantly improve survival in the majority of
patients presenting with liver metastases and their median survival is short. While the …

Microsphere and particle technology represent the next-generation agents that have formed
the basis of interventional oncology, an evolving subspecialty of interventional radiology …

Transarterial radioembolization (TARE) with yttrium 90 (90 Y), an intra-arterial procedure
performed by interventional radiologists, has begun being utilized in managing …

The liver represents a frequent site for primary and secondary neoplasia. Cytoreductive
techniques positively influence the outcome of disease progression in these patients …

Results Comparison between the 2 categories suggested that lower pretreatment level of
alpha-fetoprotein and higher tumor-to-normal uptake ratio of yttrium-90 microspheres …

OBJECTIVE. Yttrium-90 radioembolization is an emerging therapy for unresectable
hepatocellular carcinoma (HCC). Although therapeutic response based on size has been …

The past decade has seen significant advancement in the locoregional management of liver
tumors; novel and promising therapies such as transarterial chemoembolization …

An expert panel met to review the evidence for selective internal radiation therapy (SIRT)
using yttrium-90 microspheres in hepatocellular carcinoma and metastases from colorectal …

Selective internal radiation therapy with 90 Y-TheraSphere or 90 Y-SIRSphere is used in the
treatment of unresectable hepatic malignancies. To the best of our knowledge, this is the first …

Hepatocellular carcinoma (HCC) is a malignant tumour of the hepatocyte. It is a common
malignancy worldwide and causes almost half a million deaths annually. Asia is a high risk …